I agree FB. I admit my tweet to Dr Patterson baited him to reaffirm his belief in Leronlimab. But in reality from his Ted talk where he enthusiastically espoused the MOA trifecta, calmed the cytokine storm. Immune system restoration, and viral load to zero, I certainly wouldn’t have thought the trial needed such specific criteria, such as only critical over 65. So with all due respect it’s easy after the fact suggest the trial was flawed. The improve SOC however was always a legitimate concern.